Safety and Efficacy of TOP1630 for Dry Eye Syndrome

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye Syndrome

In brief

In subjects with Dry Eye Syndrome: The primary objective of this study is to compare the safety and tolerability of TOP1630 Ophthalmic Solution to placebo. The secondary objectives are to compare the efficacy of TOP1630 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye syndrome.

Key facts

Study ID
NCT03088605
Run by
ORA, Inc.
People needed
69
Starts
2017-02-20
Expected to finish
2017-06-15
Last updated by the study team
2024-02-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.